Catalina Capital Group, LLC Connect Biopharma Holdings LTD Transaction History
Catalina Capital Group, LLC
- $304 Billion
- Q4 2024
A detailed history of Catalina Capital Group, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Catalina Capital Group, LLC holds 47,867 shares of CNTB stock, worth $48,345. This represents 0.02% of its overall portfolio holdings.
Number of Shares
47,867Holding current value
$48,345% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CNTB
# of Institutions
12Shares Held
3.06MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$2.11 Million1.77% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$515,8080.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny176KShares$177,2550.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$104,9290.0% of portfolio
-
Callan Capital, LLC La Jolla, CA41.8KShares$42,2410.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $55.6M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...